Weave Bio announced a collaboration with Takeda to deploy the Weave platform across 14 active programs in multiple global markets. The collaboration brings together Weave’s AI capabilities and Takeda’s regulatory expertise to support innovation in regulatory workflows.
Press release
Weave Bio Announces Collaboration with Takeda to Deploy AI-Native Regulatory Automation Across Key Drug Development Activities
Related news
Press release
Two Former FDA Leaders Join Weave Bio’s Strategic Advisory Board
Press release
Weave Bio Enables Global Submissions
News
The Regulatory Expert Is Not Obsolete: Redefining Human Expertise in an AI-Accelerated Submission Environment
Press release